Stay Informed

Our peer-reviewed journals, feature your noteworthy discoveries and important scientific advances that shape the future of hormone health

  • Endocrine Reviews—Publishes authoritative review articles on research topics in endocrinology and related areas
  • Endocrinology—Disseminates emerging hormone science to scientists, clinicians, and the public.
  • Journal of the Endocrine Society—Publishes research, tools, methods, databases, images, and other advances in basic science, clinical science, and clinical practice in endocrinology.
  • The Journal of Clinical Endocrinology and Metabolism—Publishes clinical research and practice information in the pathophysiology, diagnosis, and treatment of endocrine and metabolic disorders.

We also offer monthly, curated, Thematic Issues of journal articles; News, updates, editorials, and more in our member magazine Endocrine News; and audio on-the-go with the Endocrine News Podcast, spotlighting breakthroughs in hormone science.

In Endocrine News

Members Advocate for Increased Federal Funding for Research

Endocrine Society members this spring urged Congress to provide an increase of $3.2 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2022, resulting in a total of $46.1 billion. Members discussed the importance of steady sustained increased funding for NIH, and the positive impact federal funding has on research discoveries in their own districts and states.

Endocrine Society members this spring urged Congress to provide an increase of $3.2 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2022, resulting in a total of $46.1 billion. Members discussed the importance of steady sustained increased funding for NIH, and the positive impact federal funding has on research discoveries in their own districts and states.

In Endocrine News

Increased Risk of Hearing Impairment with TED Treatment

More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease TED), teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021. Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for TED.

More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease TED), teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021. Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for TED.

Thematic Issues
Publishing Your Research

Tips on Getting Published in Endocrine Society Journals

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Grants & Funding

Research Opportunities

Research Policy
Explore resources for pursuing endocrine-related research opportunities.
Grants & Funding

Research Opportunities

Explore resources for pursuing endocrine-related research opportunities.

Actions & Opportunities

Advocacy Calendar

Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.
Actions & Opportunities

Advocacy Calendar

Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!